DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,471,611 | +23.4% | 1,735,073 | +19.4% | 0.33% | +26.2% |
| Q2 2023 | $348,716,160 | -12.2% | 1,452,984 | -7.8% | 0.26% | -16.0% |
| Q1 2023 | $397,195,207 | -16.2% | 1,576,231 | -11.7% | 0.31% | -19.1% |
| Q4 2022 | $473,744,177 | +5.5% | 1,784,885 | +2.7% | 0.39% | -2.0% |
| Q3 2022 | $449,076,000 | -9.1% | 1,738,648 | -10.8% | 0.40% | -2.2% |
| Q2 2022 | $494,270,000 | +2.6% | 1,949,629 | +18.8% | 0.40% | +22.8% |
| Q1 2022 | $481,578,000 | -11.9% | 1,641,761 | -1.2% | 0.33% | -5.2% |
| Q4 2021 | $546,870,000 | -20.6% | 1,662,169 | -26.5% | 0.35% | -26.3% |
| Q3 2021 | $688,429,000 | +35.4% | 2,261,294 | +19.4% | 0.47% | +35.7% |
| Q2 2021 | $508,322,000 | +5.5% | 1,894,180 | -11.6% | 0.35% | -2.0% |
| Q1 2021 | $482,030,000 | -4.4% | 2,141,592 | -5.6% | 0.35% | -9.9% |
| Q4 2020 | $504,005,000 | +0.4% | 2,268,862 | -2.7% | 0.39% | -11.7% |
| Q3 2020 | $502,066,000 | +12.6% | 2,331,611 | -7.6% | 0.44% | +5.2% |
| Q2 2020 | $445,999,000 | +46.8% | 2,522,189 | +14.9% | 0.42% | +16.9% |
| Q1 2020 | $303,863,000 | -11.8% | 2,195,381 | -2.2% | 0.36% | +10.4% |
| Q4 2019 | $344,356,000 | -19.4% | 2,243,652 | -24.1% | 0.33% | -23.5% |
| Q3 2019 | $427,174,000 | -16.4% | 2,957,655 | -17.2% | 0.43% | -15.6% |
| Q2 2019 | $510,775,000 | +4.5% | 3,573,856 | -3.4% | 0.51% | +2.6% |
| Q1 2019 | $488,549,000 | +32.8% | 3,700,569 | +3.7% | 0.50% | +17.9% |
| Q4 2018 | $367,857,000 | +10.6% | 3,567,269 | +16.6% | 0.42% | +29.6% |
| Q3 2018 | $332,563,000 | +22.8% | 3,060,583 | +11.5% | 0.32% | +18.7% |
| Q2 2018 | $270,805,000 | -0.9% | 2,744,276 | -1.7% | 0.27% | -1.8% |
| Q1 2018 | $273,298,000 | +4.0% | 2,791,323 | -1.5% | 0.28% | +6.1% |
| Q4 2017 | $262,909,000 | +96.5% | 2,832,466 | +81.6% | 0.26% | +94.1% |
| Q3 2017 | $133,819,000 | -3.6% | 1,560,026 | -5.1% | 0.14% | -6.2% |
| Q2 2017 | $138,795,000 | -15.8% | 1,644,688 | -14.7% | 0.14% | -15.8% |
| Q1 2017 | $164,937,000 | +129.0% | 1,928,414 | +108.5% | 0.17% | +119.2% |
| Q4 2016 | $72,010,000 | +2.1% | 925,108 | +2.8% | 0.08% | +1.3% |
| Q3 2016 | $70,535,000 | -20.1% | 899,797 | +2.9% | 0.08% | -23.0% |
| Q2 2016 | $88,276,000 | +1430.2% | 874,019 | +1191.0% | 0.10% | +1328.6% |
| Q3 2015 | $5,769,000 | +0.1% | 67,701 | +0.6% | 0.01% | +16.7% |
| Q2 2015 | $5,762,000 | +16.3% | 67,324 | +15.4% | 0.01% | 0.0% |
| Q1 2015 | $4,953,000 | -23.3% | 58,342 | -22.6% | 0.01% | -14.3% |
| Q4 2014 | $6,457,000 | -82.3% | 75,340 | -84.3% | 0.01% | -83.7% |
| Q3 2014 | $36,567,000 | +4.0% | 481,265 | +7.8% | 0.04% | +7.5% |
| Q2 2014 | $35,162,000 | -43.1% | 446,618 | -45.8% | 0.04% | -45.2% |
| Q1 2014 | $61,825,000 | -75.2% | 824,337 | -74.5% | 0.07% | -75.1% |
| Q4 2013 | $249,170,000 | +30.5% | 3,227,588 | +17.2% | 0.29% | +22.6% |
| Q3 2013 | $190,901,000 | +10.6% | 2,753,908 | +1.0% | 0.24% | +4.8% |
| Q2 2013 | $172,601,000 | – | 2,726,716 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |